SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000905148-11-000608
Filing Date
2011-03-09
Accepted
2011-03-09 17:28:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc11-209_sc13da.htm SC 13D/A 58222
  Complete submission text file 0000905148-11-000608.txt   59704
Mailing Address 160 SECOND STREET CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE MA 02142 617-492-5554
Molecular Insight Pharmaceuticals, Inc. (Subject) CIK: 0001340752 (see all company filings)

IRS No.: 043412465 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82504 | Film No.: 11676064
SIC: 2834 Pharmaceutical Preparations

Mailing Address 450 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 450 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-209-3100
Taconic Capital Advisors LP (Filed by) CIK: 0001390113 (see all company filings)

IRS No.: 205826144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A